Introduction 22
Colorectal cancer (CRC) is among the most common cancers worldwide 1 . While early CRC stages 23 are highly treatable by surgical removal, later stages are usually incurable 2 . CRC arises through a 24 multi-step process from small lesions of the epithelium of the large intestine. These lesions grow 25 into adenomas with low grade dysplasia that progress into high grade dysplasia, eventually giving 26 rise to infiltrating carcinomas 3 . Genetic mutations in signalling pathways such as the canonical 27
Wnt signalling are the molecular basis of CRC 4 . However, the interaction of the tumour with its 28 microenvironment is another critical hallmark 
Results

49
CRC organoids express immunomodulatory molecules 50
We first assessed whether CRC organoids expressed immunomodulatory molecules in established 51 long-term expanded cultures. Therefore, we compared gene expression of T-cell-specific 52 immunomodulators in CRC organoids to the expression levels found in normal colon organoids 53 using a transcriptome dataset generated using our 'living organoid biobank' of CRC patients 12 .
On 54 average, transcription of genes associated with T-cell stimulation such as TNFSF4 or TNFSF9 was 55 not altered in CRC organoids compared to normal colon organoids (Fig. 1a) . However, expression 56 of human leukocyte antigen (HLA) genes HLA-A and HLA-C, encoding major histocompatibility 57 complex class (MHC)-I molecules that present antigens to T cells, were significantly 58 downregulated in CRC organoids (Fig. 1a) , a well-described phenomenon found in cancers 13 . 59
Expression of genes associated with inhibition of T-cell function was either significantly 60 upregulated such as BTLA, significantly downregulated such as CD80, CD86 or LGALS9 or not 61 altered at all such as CD274 (encoding PD-L1), PDCD1LG2 (encoding PD-L2) (Fig. 1a) . When and LGALS9 compared to healthy colon organoids (Fig. 1b) . However, expression of 65 immunoinhibitory genes CD274and PDCD1LG2, for instance, was highly upregulated in some 66 CRC organoids in comparison to the matched normal colon organoid cultures, reflecting 67 previously reported preservation of tumour heterogeneity in organoids 12 (Fig. 1b) 
SMAD4
KO/KO ) showed lower CD274 gene expression in comparison to control wild-type organoids 83 (Fig. 1 c) . Overall, PD-L1 expression was low in untreated organoid lines ( Fig. 1 c,d ). However, 84 PD-L1 expression was dramatically upregulated in IFN-γ-treated organoids both on transcript and 85 protein level ( Fig. 1 c,d ). These data demonstrate that CRC organoids express immunomodulators 86 and that this expression is regulated in a similar way as previously shown for tissue in vivo. 87
88
CRC organoids as tools for assessment of antigen specific killing by CD8 + T cells 89
We next aimed at establishing a co-culture system for CRC organoids and CTLs to model antigen-90 specific killing of tumour cells in vitro. For this, we used ab T cells carrying a transgenic T-cell 91 receptor (TCR) recognizing an HLA-A2-restricted Wilms tumour (WT)1-derived peptide 18, 19 . 92
Therefore, we first screened CRC organoids from the 'living biobank' 12 as well as newly generated 93 Bar-Ephraim, Kretzschmar et al.
4
CRC organoids for HLA-A2 expression using flow cytometry. Interestingly, we found three CRC 94 organoid lines that showed partial downregulation of HLA-A2 ( Supplementary Fig. 1a ). We were 95 able to purify HLA-A2 + and HLA-A2 -CRC organoids and successfully established cultures from 96 both populations (Fig. 2b) . We confirmed stable MHC-I downregulation in HLA-A2 -CRC 97 organoids, as IFN-γ stimulation did not trigger HLA-A2 re-expression ( Supplementary Fig. 1b) . 98
Next, we pulsed these CRC organoid lines with WT1 peptide and, subsequently, co-cultured them 99
for 48 hours with peptide-specific T cells. Following co-culture, we found that HLA-A2 -CRC 100 organoids did survive irrespective of whether pulsed with the peptide or not (Fig. 2c) . However, 101 only the HLA-A2 + CRC organoids without prior peptide incubation survived co-culture (Fig. 2c) . 102
Peptide-pulsed HLA-A2 + CRC organoids were effectively killed by the peptide-specific T cells 103 providing a proof-of-principle that organoids can be utilised to study anti-tumour response by 104 cytotoxic T cells in vitro. 105
To further confirm antigen-specificity in our 'killing' assay system, we improved our co-106 culture method by transfecting HLA-A2 + CRC organoids with a construct expressing 107 mNeonGreen-tagged histone H2B and staining T cells with CellTracker violet to allow for long-108 term tracking of both cell types (Methods). We then pulsed HLA-A2 + CRC organoids with either 109 the WT1 peptide or with an EBV-derived peptide (Methods) and co-cultured the organoids with T 110 cells carrying either a WT1-or an EBV-specific TCR. Here, only organoids pulsed with the 111 cognate peptide were efficiently killed by the T cells (Fig. 2d, Supplementary Movies 1 and 2) . 112
Testing for IFN-γ production by the T cells in the co-culture using enzyme-linked immunosorbent 113 assay (ELISA) confirmed antigen-specific organoid killing by the T cells (Fig. 2e) . In order to 114 better follow the kinetics of the organoid killing, we applied to a fluorescent dye (NucRed Dead 115 647, Methods), which specifically stains apoptotic cells, and performed live confocal imaging on 116 the co-culture (Fig. 2f) . We then quantified organoid killing by assessing co-localization of 117
NucRed Dead dye with H2B-mNeonGreen (Methods). Significant co-localisation of both labels 118 and, hence, organoid killing, was only observed when peptide-pulsed HLA-A2 + CRC organoids 119 were co-culture with the respective peptide-specific T cells (Fig. 2g) . Furthermore, T cells 120 infiltrating into the epithelium of the organoids could be readily detected in this co-culture 121 condition (Fig. 2h ). In conclusion, T cells efficiently killed co-cultured CRC organoids in an 122
antigen-specific manner. 123
Discussion 125
Here we demonstrate that epithelial organoids can be used faithfully to recapitulate the interaction 126 between tumour tissue and the immune system. Also, using our co-culture assay, we set a first step 127 
Organoid generation and cultures 147
Epithelial organoid lines were derived from healthy colon or tumor tissue as previously 148 described 12,20 . In brief, healthy colonic crypts were isolated by digestion of the colonic mucosa in 149 chelation solution (5.6 mM Na2HPO4, 8.0 mM KH2PO4, 96.2 mM NaCl, 1.6 mM KCl, 43.4 mM 150 Sucrose, and 54.9 mM D-Sorbitol, Sigma) supplemented with dithiotreitol (0.5 mM, Sigma) and 151 EDTA (2 mM, in-house), for 30 minutes at 4°C. Colon crypts were subsequently plated in 152 basement membrane extract (BME; Cultrex PC BME RGF type 2, Amsbio) and organoids were 153 grown in human intestinal stem cell medium (HISC), which is composed of Advanced Dulbecco's 154 modified Eagle medium/F12 supplemented with penicillin/streptomycin, 10 mM HEPES andGlutamax (all Gibco, Thermo Fisher Scientific) with 50% Wnt3a conditioned medium (in-house), 156 20% R-Spondin1 conditioned medium (in-house), 10% Noggin conditioned medium (in-house), 1 157 x B27, 1,25 mM n-acetyl cysteine, 10 mM nicotinamide, 50 ng/mL human EGF, 10 nM Gastrin, 158 500 nM A83-01, 3 µM SB202190, 10 nM prostaglandine E2 and 100 µg/mL Primocin (Invivogen). 159
Tumor specimens were digested to single cells in collagenase II (1 mg/mL, Gibco, Thermo 160 Scientific), supplemented with hyaluronidase (10 µg/mL) and LY27632 (10 µM) for 30 minutes 161 at 37°C while shaking. Single tumor cells were plated in BME and organoids were cultured in 162 HICS minus Wnt conditioned medium and supplemented with 10 µM LY27632 at 37°C. 163
164
Organoid transfection 165
CRC organoids were dissociated into small clumps using TrypLE and then transduced with H2B-166 mNeonGreen (pLV-H2B-mNeonGreen-ires-Puro), as previously described 21 . 167
168
T cells 169
Generation of ab T cells carrying a transgenic TCR recognizing an HLA-A2-restricted WT1-170 derived peptide were described elsewhere 18 . Briefly, TCRα and β chains were cloned from raised 171 tetramer positive T cell clones. Subsequently, CD8
+ αβ TCR T cells were transduced using 172 retroviral supernatant from Phoenix-Ampho packaging cells that were transfected with gag-pol, 173 env, and pBullet retroviral constructs containing the cloned TCR genes. 174 175
Organoid-T cell co-culture and live cell imaging 176
Organoids stably transfected with H2B-mNeonGreen were split and digested a 5 to 7 days prior to 177 co-culture and seeded at a density of 5000 cells per 10 µL of BME (25,000 cells per well in a 12-178 well cell culture plate). Two days prior to co-culture, T cells were starved from IL-2. One day prior 179 to co-culture, organoids were stimulated with IFN-γ at indicated concentrations. 180
Organoids were pulsed with TCR-specific peptide (ProImmune) for 2 hours at 37°C prior to co-181 culture. Organoids and T cells were harvested and taken up in T cell medium, supplemented with 182 10% BME, 100 IU/mL IL-2 and NucRed Dead 647 (Thermo Fischer). Where indicated, anti-PD1 183 blocking antibodies (2 µg/mL) were added to the co-culture. Cells were plated in glass-bottom 96-184 well plates and co-cultures were imaged using an SP8X confocal microscope (Leica). 185 
